• $5.99

Publisher Description

The objective of this report is to improve the quality of immunochemical measurements of B-type natriuretic peptide (BNP) [9] and its N-terminal propeptide (NT-proBNP; Table 1). The recommendations proposed are intended for use by manufacturers of commercial assays, by clinical laboratories using those assays, by clinical trial groups and research investigators, and by regulatory agencies, such as the United States Food and Drug Administration (FDA). The main objectives are as follows: * For manufacturers to endorse and then consistently follow the proposed recommendations;

GENRE
Science & Nature
RELEASED
2005
1 March
LANGUAGE
EN
English
LENGTH
23
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
197.3
KB

More Books by Clinical Chemistry